Supernus Pharm (SUPN) Misses Q4 EPS by 10c
Tweet Send to a Friend
Supernus Pharm (NASDAQ: SUPN) reported Q4 EPS of ($0.65), $0.10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
